Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Surgical Science Sweden AB (SUSW)

Stockholm
Currency in SEK
146.80
-3.00(-2.00%)
Closed
SUSW Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
144.50149.50
52 wk Range
111.80196.90
Key Statistics
Edit
Prev. Close
146.8
Open
149
Day's Range
144.5-149.5
52 wk Range
111.8-196.9
Volume
94.1K
Average Volume (3m)
123.66K
1-Year Change
-18.44%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SUSW Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
192.17
Upside
+30.91%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Surgical Science Sweden Company Profile

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a powerful training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was incorporated in 1997 and is headquartered in Gothenburg, Sweden.

Employees
260
Market
Sweden

Compare SUSW to Peers and Sector

Metrics to compare
SUSW
Peers
Sector
Relationship
P/E Ratio
39.5x−1.8x−0.7x
PEG Ratio
−1.66−0.020.00
Price/Book
1.7x2.6x2.6x
Price / LTM Sales
8.9x4.4x3.2x
Upside (Analyst Target)
27.4%55.0%44.1%
Fair Value Upside
Unlock18.5%8.2%Unlock

Analysts' Recommendations

5 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 192.17

(+30.90% Upside)

People Also Watch

546.50
CAMX
-1.09%
100.00
NEWAb
-0.40%
211.00
RAYb
-1.86%
211.00
CEVI
-0.47%
53.10
SECARE
+2.51%

FAQ

What Is the Surgical Science Sweden (SUSW) Stock Price Today?

The Surgical Science Sweden stock price today is 146.80

What Stock Exchange Does Surgical Science Sweden Trade On?

Surgical Science Sweden is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Surgical Science Sweden?

The stock symbol for Surgical Science Sweden is "SUSW."

What Is the Surgical Science Sweden Market Cap?

As of today, Surgical Science Sweden market cap is 7.49B.

What is Surgical Science Sweden Earnings Per Share?

The Surgical Science Sweden EPS is 3.79.

What Is the Next Surgical Science Sweden Earnings Date?

Surgical Science Sweden will release its next earnings report on 19 Feb 2025.

From a Technical Analysis Perspective, Is SUSW a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.